Revival
Catalent’s Revival: Are the Dark Days Behind It Ahead of Novo Holdings Acquisition?
Catalent, Novo Holdings, acquisition, pharmaceutical industry, revenue boost, dark days, revival
Revitalizing Cancer Therapy: UK Biotech Acquires Kyowa Kirin’s Former Drug for Epstein-Barr-Related Diseases
UK Biotech, Kyowa Kirin, cancer drug, Epstein-Barr virus, EBV-driven diseases, drug acquisition, therapy revival.